Specify a stock or a cryptocurrency in the search bar to get a summary
Biostem Technologies Inc
BSEMBioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr. Dave's Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally. The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida. Address: 2836 Center Port Circle, Pompano Beach, FL, United States, 33064
Analytics
WallStreet Target Price
24.25 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures BSEM
Dividend Analytics BSEM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History BSEM
Stock Valuation BSEM
Financials BSEM
Results | 2019 | Dynamics |